NCT00861367撤回不适用
Prospektive Doppel-Blind-randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen
University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 试验地点
- 1
- 主要终点
- Blood loss
研究概览
简要总结
Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Transurethral surgery of the bladder or prostate, informed consent, age over 18
排除标准
- •Oral anticoagulation,
研究组 & 干预措施
1
Active Comparator
aspirin 100mg
干预措施: transurethral surgery with or without aspirin (Drug)
2
Placebo Comparator
empty capsule
干预措施: transurethral surgery with or without aspirin (Drug)
结局指标
主要结局
Blood loss
时间窗: intraoperative, 6 hours post op, 3 days postop
次要结局
- Reoperation rates(during hospitalization)
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyEarly NephropathyType 2 DiabetesNCT00157508Mario Negri Institute for Pharmacological Research13
招募中
3 期
Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High RiskColorectal CancerNCT02945033University Hospital, Rouen264
Unknown
4 期
Antiaggregation in Primary Prevention of Vascular Access for HemodialysisThrombosisNCT02055131Tunis University300
进行中（未招募）
4 期
ASCEND: A study of cardiovascular events in diabetesDiabetes (type 1 & 2)Nutritional, Metabolic, EndocrineDiabetesISRCTN60635500niversity of Oxford (UK)15,480
Unknown
不适用
Aspirin in Reducing Events in the ElderlyFunctional DisabilityHeart DiseaseBleedingCancerStrokeDementiaDepressionNCT01038583Hennepin Healthcare Research Institute19,114